Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) Sees Large Volume Increase – Here’s What Happened

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) saw strong trading volume on Tuesday . 311,679 shares traded hands during mid-day trading, an increase of 251% from the previous session’s volume of 88,883 shares.The stock last traded at $9.94 and had previously closed at $10.02.

Shionogi & Co., Ltd. Unsponsored ADR Trading Up 1.8%

The company has a quick ratio of 5.74, a current ratio of 6.44 and a debt-to-equity ratio of 0.01. The firm has a market cap of $17.22 billion, a PE ratio of 15.81, a P/E/G ratio of 2.07 and a beta of 0.19. The firm has a 50 day moving average of $8.98 and a 200 day moving average of $8.71.

Shionogi & Co., Ltd. Unsponsored ADR (OTCMKTS:SGIOY) last issued its earnings results on Monday, October 27th. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.02. Shionogi & Co., Ltd. Unsponsored ADR had a net margin of 39.53% and a return on equity of 11.90%. The business had revenue of $740.85 million for the quarter, compared to analysts’ expectations of $742.35 million. Equities analysts anticipate that Shionogi & Co., Ltd. Unsponsored ADR will post 0.66 earnings per share for the current year.

About Shionogi & Co., Ltd. Unsponsored ADR

Shionogi & Co, Ltd. is a Japan-based pharmaceutical company that conducts research, development, manufacturing and marketing of prescription drugs and vaccines. Established in the late 19th century, the company has expanded its focus beyond domestic markets to become a global player in pharmaceuticals, with particular expertise in anti-infectives, pain management, cardiovascular and central nervous system disorders.

The company’s product portfolio spans both established and innovative therapies.